Unlike, PC-3 and LNCaP cells, DU145 prostate cancer cells do not show ATG5 expression and consequently are unable to form functional ATG12–ATG5 conjugation complexes, resulting in an impairment of LC3 lipidation. Here, ATG5 is linked to prostate cancer.